dihydrokainate has been researched along with morphine in 3 studies
| Studies (dihydrokainate) | Trials (dihydrokainate) | Recent Studies (post-2010) (dihydrokainate) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 180 | 0 | 46 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | dihydrokainate (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terman, GW; Thomson, LM; Zeng, J | 1 |
| Baron, DA; Patel, D; Patel, H; Rawls, SM; Sacavage, S; Zielinski, M | 1 |
| Li, J; Lu, XQ; Su, RB; Wu, N; Yan, HT; Zheng, JQ | 1 |
3 other study(ies) available for dihydrokainate and morphine
| Article | Year |
|---|---|
Differential effect of glutamate transporter inhibition on EPSCs in the morphine naïve and morphine tolerant neonatal spinal cord slice.
Topics: 2-Amino-5-phosphonovalerate; Amino Acid Transport System X-AG; Analysis of Variance; Animals; Aspartic Acid; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Kainic Acid; Morphine; Narcotics; Patch-Clamp Techniques; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Spinal Cord | 2006 |
Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation.
Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; Ceftriaxone; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Transporter 2; Hot Temperature; Injections, Intraperitoneal; Injections, Subcutaneous; Kainic Acid; Male; Morphine; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reaction Time | 2010 |
Aquaporin-4 deficiency attenuates opioid dependence through suppressing glutamate transporter-1 down-regulation and maintaining glutamate homeostasis.
Topics: Animals; Aquaporin 4; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Down-Regulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Homeostasis; Kainic Acid; Mice; Mice, Knockout; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Tritium | 2013 |